Tandem Diabetes Care (TNDM) Current Leases (2019 - 2026)

Tandem Diabetes Care (TNDM) has 8 years of Current Leases data on file, last reported at $20.1 million in Q1 2026.

• For the quarter ending Q1 2026, Current Leases fell 2.92% year-over-year to $20.1 million; the trailing twelve-month figure through Mar 2026 stood at $20.1 million (down 2.92% YoY), and the FY2025 full-year result was $19.5 million, up 6.94% from the prior year.
• Current Leases for Q1 2026 stood at $20.1 million, up from $19.5 million in the prior quarter.
• Across five years, Current Leases topped out at $21.3 million in Q3 2025 and bottomed at $8.1 million in Q1 2022.
• The 5-year median for Current Leases is $17.8 million (2023), against an average of $16.7 million.
• The widest annual swing landed in 2022, when Current Leases fell 14.46%; it then jumped 96.15% in 2023.
• A 5-year view of Current Leases shows it stood at $13.1 million in 2022, then soared by 30.02% to $17.1 million in 2023, then grew by 6.73% to $18.2 million in 2024, then gained by 6.94% to $19.5 million in 2025, then grew by 3.27% to $20.1 million in 2026.
• The last three Current Leases figures came in at $20.1 million (Q1 2026), $19.5 million (Q4 2025), and $21.3 million (Q3 2025), per Business Quant data.

Peer Comparison